1. Delivery of liposome-encapsulated drugs to macrophages;Alving;Pharmacol. Ther.,1983
2. Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine;Bennett;Cancer Treat. Rep.,1986
3. The adsorption of proteins to pharmaceutical container surfaces;Burke;Int. J. Pharm.,1992
4. Systemic macrophage activation with liposome-entrapped immunomodulators for therapy of cancer metastasis;Fidler,1992
5. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-y encapsulated in liposomes;Fidler;J. Immunol.,1985